192 related articles for article (PubMed ID: 32562808)
1. Left ventricular dysfunction in COVID-19: A diagnostic issue.
Jacquet-Lagrèze M; Riad Z; Hugon-Vallet E; Ferraris A; Fellahi JL
Anaesth Crit Care Pain Med; 2020 Jun; 39(3):393-394. PubMed ID: 32562808
[No Abstract] [Full Text] [Related]
2. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
Chorin E; Dai M; Shulman E; Wadhwani L; Bar-Cohen R; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Chinitz LA; Jankelson L
Nat Med; 2020 Jun; 26(6):808-809. PubMed ID: 32488217
[No Abstract] [Full Text] [Related]
3. COVID-19 and QT interval prolongation: more than just drug toxicity?
Merino JL; Martínez-Cossiani M; Iniesta A; Escobar C; Rey JR; Castrejón-Castrejón S
Europace; 2020 Oct; 22(10):1479. PubMed ID: 32441761
[No Abstract] [Full Text] [Related]
4. Emerging cardiological issues during the COVID-19 pandemic.
Everaert BR; Muylle J; Bartholomeus Twickler T
Eur J Clin Invest; 2020 Jul; 50(7):e13270. PubMed ID: 32415992
[No Abstract] [Full Text] [Related]
5. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R
Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366
[TBL] [Abstract][Full Text] [Related]
6. Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin.
Anupama BK; Adhikari S; Chaudhuri D
J Investig Med High Impact Case Rep; 2020; 8():2324709620948407. PubMed ID: 32762368
[TBL] [Abstract][Full Text] [Related]
7. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
[TBL] [Abstract][Full Text] [Related]
8. Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval.
Samuel S; Friedman RA; Sharma C; Ganigara M; Mitchell E; Schleien C; Blaufox AD
Heart Rhythm; 2020 Nov; 17(11):1960-1966. PubMed ID: 32621881
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 associated viral myocarditis: does it exist?
Verma V; Sondhi S; Sharma R; Mahajan K
Monaldi Arch Chest Dis; 2020 Sep; 90(4):. PubMed ID: 32945641
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
Javelot H; El-Hage W; Meyer G; Becker G; Michel B; Hingray C
Br J Clin Pharmacol; 2020 Jun; 86(6):1176-1177. PubMed ID: 32350872
[No Abstract] [Full Text] [Related]
11. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology.
Pani A; Lauriola M; Romandini A; Scaglione F
Int J Antimicrob Agents; 2020 Aug; 56(2):106053. PubMed ID: 32534189
[TBL] [Abstract][Full Text] [Related]
12. Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment.
Roden DM; Harrington RA; Poppas A; Russo AM
Heart Rhythm; 2020 Jul; 17(7):e231-e232. PubMed ID: 32302703
[No Abstract] [Full Text] [Related]
13. [Non-ischemic ventricular dysfunction in COVID-19 patients: characteristics and implications for cardiac imaging on the basis of current evidence].
Mele D; D'Andrea A; Campana M; Di Giannuario G; Flamigni F; Gimelli A; Khoury G; Rizzo M; Moreo A
G Ital Cardiol (Rome); 2020 Oct; 21(10):739-749. PubMed ID: 32968306
[TBL] [Abstract][Full Text] [Related]
14. [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].
Tomcsányi J; Tomcsányi K
Orv Hetil; 2020 Apr; 161(17):689-691. PubMed ID: 32324363
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
Horowitz NA; Brenner B
Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920
[No Abstract] [Full Text] [Related]
16. First Documentation of Persistent SARS-Cov-2 Infection Presenting With Late Acute Severe Myocarditis.
Pavon AG; Meier D; Samim D; Rotzinger DC; Fournier S; Marquis P; Monney P; Muller O; Schwitter J
Can J Cardiol; 2020 Aug; 36(8):1326.e5-1326.e7. PubMed ID: 32522523
[TBL] [Abstract][Full Text] [Related]
17. Acute meningoencephalitis in a patient with COVID-19.
Chaumont H; Etienne P; Roze E; Couratier C; Roger PM; Lannuzel A
Rev Neurol (Paris); 2020 Jun; 176(6):519-521. PubMed ID: 32414534
[No Abstract] [Full Text] [Related]
18. Cardiac considerations in patients with COVID-19.
Calvillo-Argüelles O; Ross HJ
CMAJ; 2020 Jun; 192(23):E630. PubMed ID: 32357998
[No Abstract] [Full Text] [Related]
19. Immune-Mediated Coagulopathy in COVID-19 Infection.
Vadasz Z; Brenner B; Toubi E
Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
[No Abstract] [Full Text] [Related]
20. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.
Yahya AS; Khawaja S; Chukwuma J
Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32441496
[No Abstract] [Full Text] [Related]
[Next] [New Search]
